52 related articles for article (PubMed ID: 12615444)
21. Regioselective Sequential Modification of Chitosan via Azide-Alkyne Click Reaction: Synthesis, Characterization, and Antimicrobial Activity of Chitosan Derivatives and Nanoparticles.
Sarwar A; Katas H; Samsudin SN; Zin NM
PLoS One; 2015; 10(4):e0123084. PubMed ID: 25928293
[TBL] [Abstract][Full Text] [Related]
22. Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.
Xu Y; Yuen PW; Lam JK
Pharmaceutics; 2014 Jul; 6(3):378-415. PubMed ID: 25014738
[TBL] [Abstract][Full Text] [Related]
23. Chitosans for delivery of nucleic acids.
Buschmann MD; Merzouki A; Lavertu M; Thibault M; Jean M; Darras V
Adv Drug Deliv Rev; 2013 Aug; 65(9):1234-70. PubMed ID: 23872012
[TBL] [Abstract][Full Text] [Related]
24. Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice.
Liu Z; Lv D; Liu S; Gong J; Wang D; Xiong M; Chen X; Xiang R; Tan X
PLoS One; 2013; 8(4):e60190. PubMed ID: 23577091
[TBL] [Abstract][Full Text] [Related]
25. DNA-based applications in nanobiotechnology.
Abu-Salah KM; Ansari AA; Alrokayan SA
J Biomed Biotechnol; 2010; 2010():715295. PubMed ID: 20652049
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of mucoadhesive PLGA microparticles for nasal immunization.
Pawar D; Goyal AK; Mangal S; Mishra N; Vaidya B; Tiwari S; Jain AK; Vyas SP
AAPS J; 2010 Jun; 12(2):130-7. PubMed ID: 20077052
[TBL] [Abstract][Full Text] [Related]
27. RSV fusion (F) protein DNA vaccine provides partial protection against viral infection.
Wu H; Dennis VA; Pillai SR; Singh SR
Virus Res; 2009 Oct; 145(1):39-47. PubMed ID: 19540885
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary DNA vaccination: concepts, possibilities and perspectives.
Bivas-Benita M; Ottenhoff TH; Junginger HE; Borchard G
J Control Release; 2005 Sep; 107(1):1-29. PubMed ID: 16054263
[TBL] [Abstract][Full Text] [Related]
29. DNA vaccines for cancer too.
Yu M; Finn OJ
Cancer Immunol Immunother; 2006 Feb; 55(2):119-30. PubMed ID: 16032397
[No Abstract] [Full Text] [Related]
30. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
Johnson TR; Graham BS
Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
[TBL] [Abstract][Full Text] [Related]
31. Mucosal gene expression vaccine: a novel vaccine strategy for respiratory syncytial virus.
Mohapatra SS
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S100-3; discussion S103-4. PubMed ID: 12671460
[TBL] [Abstract][Full Text] [Related]
32. Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice.
Iqbal M; Lin W; Jabbal-Gill I; Davis SS; Steward MW; Illum L
Vaccine; 2003 Mar; 21(13-14):1478-85. PubMed ID: 12615444
[TBL] [Abstract][Full Text] [Related]
33. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection.
Kumar M; Behera AK; Lockey RF; Zhang J; Bhullar G; De La Cruz CP; Chen LC; Leong KW; Huang SK; Mohapatra SS
Hum Gene Ther; 2002 Aug; 13(12):1415-25. PubMed ID: 12215263
[TBL] [Abstract][Full Text] [Related]
34. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
[TBL] [Abstract][Full Text] [Related]
35. Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus.
Jiang S; Borthwick NJ; Morrison P; Gao GF; Steward MW
J Gen Virol; 2002 Feb; 83(Pt 2):429-438. PubMed ID: 11807236
[TBL] [Abstract][Full Text] [Related]
36. Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses.
Simmons CP; Hussell T; Sparer T; Walzl G; Openshaw P; Dougan G
J Immunol; 2001 Jan; 166(2):1106-13. PubMed ID: 11145691
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
